Predictors of galcanezumab response in a real-world study of Korean patients with migraine

被引：0
|
作者：
Kim, Seung Ae [1 ]
Lee, Mi Ji [1 ]
Jang, Hyemin [2 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [1] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Seung Ae Kim
    Hyemin Jang
    Mi Ji Lee
    Scientific Reports, 13
  • [2] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Kim, S.
    Jang, H.
    Lee, M.
    HEADACHE, 2023, 63 : 154 - 155
  • [3] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Kim, Seung Ae
    Jang, Hyemin
    Lee, Mi Ji
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Hyoung Cheol Lee
    Soohyun Cho
    Byung-Kun Kim
    Neurological Sciences, 2023, 44 : 2455 - 2463
  • [5] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2455 - 2463
  • [6] Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients
    Kwon, Soonwook
    Gil, Young-Eun
    Lee, Mi Ji
    CEPHALALGIA, 2022, 42 (08) : 705 - 714
  • [7] Predictors of galcanezumab response in Korean patients with migraine
    Kim, S. A.
    Jang, H.
    Lee, M.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [8] Predictors of response to galcanezumab in patients with chronic migraine; real world data
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 2 - 2
  • [9] Real-world study of migraine patients treated with galcanezumab or topiramate in the German NeuroTransData network
    Koechling, M.
    Tozzi, V.
    Israel-Willner, H.
    Paddock, S.
    Rossnagel, F.
    Lutz, N.
    Kestler, J.
    Schwerdtner, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 584 - 585
  • [10] Galcanezumab for migraine prevention in patients above 65: a multicenter study in real-world settings
    Peris-Subiza, J.
    Guisado-Alonso, D.
    Cuadrado Godia, E.
    Velasco Juanes, F.
    Alvarez Escudero, R.
    Riesco Perez, N.
    Gonzalez-Fernandez, L.
    Oterino Duran, A.
    Martin Bujanda, M.
    Aranceta Arilla, S.
    Ruisanchez Nieva, A.
    Roncero, N.
    Garcia-Monco, J. C.
    Minguez-Olaondo, A.
    Ruibal Salgado, M.
    Echeverria Urabayen, A.
    Kortazar Zubizarreta, I.
    Lopez-Bravo, A.
    Guerrero Peral, A. L.
    Garcia Azorin, D.
    Fabregat Fabra, N.
    Fernandez-Fernandez, S.
    Obach Baurier, V.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345